Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
04-02-01 First-Generation Antipsychotic Drugs
Injection| Flupentixol Depixol® |
|
Formulary
|
Tablets 500microgram, 1mg, 3mg For the treatment of schizophrenia and other psychoses
|
|
| Haloperidol |
|
Formulary
|
Tablets 1.5mg, 5mg, 10mg |
 MHRA: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium |
|
| Haloperidol |
|
Formulary
|
| Injection 5mg/1mL |
|
MHRA: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium |
|
Links
- Aripiprazole for the treatment of schizophrenia in people aged 15 -17 years (NICE TA 213)
- Bipolar disorder (children) - aripiprazole (NICE TA292)
LSCFT - Cariprazine medicine request form- LSCFT - Clozapine injection medication request form
- LSCFT - Lurasidone medicine request form
- LSCFT - Quetiapine XL medicine request form
LSCMMG SCG antipsychotics- LSCMMG SCG antipsychotics
- LSCMMG SCG Antipsychotics
- LSCMMG SCG Antipsychotics
- LSCMMG SCG Antipsychotics
- LSCMMG SCG Antipsychotics
- LSCMMG: Dementia medicine prescribing information sheet
- LSCMMG: Management of Behavioural and Psychological Symptoms of Dementia (BPSD) in Primary and Secondary Care
- LSCMMG: Management of Behavioural and Psychological Symptoms of Dementia (BPSD). Summary document for Primary Care
- LSCMMG: Shared care guideline
- LSCMMG: Shared care guideline
- LSCMMG: Shared care guideline
- LSCMMG: Shared care guideline
- LSCMMG: Shared care guideline
- LSCMMG: Shared care guideline
- MHRA Drug Safety Update Aug 2020: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA Drug Safety Update Aug 2020: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA Drug Safety Update Aug 2020: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA Drug Safety Update December 2021: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
- MHRA Drug Safety Update December 2021: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
- MHRA Drug Safety Update Oct 2017: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA Drug Safety Update Oct 2017: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA Drug Safety Update Oct 2017: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA: Clozapine and other antipsychotics: monitoring blood concentrations for toxicity
- MHRA: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus
- MHRA: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
- MHRA: Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium
- NICE CG103: Delirium: prevention, diagnosis and management
- NICE CG178 Psychosis and schizophrenia in adults: prevention and management
- NICE Evidence summary: Quetiapine for generalised anxiety disorder
- NICE TA213: Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years
- NICE TA292: Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder